Hogan Lovells US LLP

Hogan Lovells US LLP maintains a broad life sciences and healthcare practice spanning IP licensing, regulatory, and transactional matters. The team advises on complex licensing and collaboration agreements involving IP at all stages of the product lifecycle, including work with emerging and cutting-edge companies. The practice has also developed a focus on energy demand issues affecting life sciences businesses. Leadership of the team includes Philadelphia-based Steve Abrams, co-head of the firm’s life sciences and healthcare industry sector, who advises on capital markets offerings, collaboration and licensing transactions, and M&A matters, and Washington, DC-based Lynn Mehler, fellow co-head of the life sciences sector and head of the pharmaceuticals and biotechnology regulatory practice. The practice’s regulatory capabilities are further reflected in the medical device and technology regulatory division, co-led by Jodi Scott and John Smith; Scott advises on FDA inspections and enforcement matters from Denver, while Smith focuses on bringing device-based technologies to market, including AI-based image analysis tools, from Washington, DC. Cullen Taylor co-leads the life sciences licensing and commercial transactions team from Northern Virginia, and in Washington, DC David Fox and Komal Karnik Nigam advise on new drug approvals, regulatory compliance, and product lifecycle exclusivity issues.